INCYTE CORPORATION Finance Lease, Principal Payments
INCYTE CORPORATION (INCY) reported Finance Lease, Principal Payments of $1.18 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-04-28
- INCYTE CORPORATION finance lease, principal payments for the quarter ending 2026-03-31 was $1.18M, a 8.62% increase year-over-year.
- INCYTE CORPORATION finance lease, principal payments for the quarter ending 2025-12-31 was $1.16M, a 11.67% increase year-over-year.
- INCYTE CORPORATION finance lease, principal payments for the quarter ending 2025-09-30 was $1.14M, a 16.55% increase year-over-year.
- INCYTE CORPORATION finance lease, principal payments for the quarter ending 2025-06-30 was $1.16M, a 26.78% increase year-over-year.
- INCYTE CORPORATION finance lease, principal payments for fiscal 2025 was $4.54M, a 19.64% increase from fiscal 2024.
- INCYTE CORPORATION finance lease, principal payments for fiscal 2024 was $3.80M, a 13.04% increase from fiscal 2023.
- INCYTE CORPORATION finance lease, principal payments for fiscal 2023 was $3.36M, a 17.40% increase from fiscal 2022.
- INCYTE CORPORATION finance lease, principal payments for fiscal 2022 was $2.86M, a 18.41% increase from fiscal 2021.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.18M 10-Q · filed 2026-04-28 | $2.34M derived: sum of 2 quarters · filed 2026-04-28 | $3.48M derived: sum of 3 quarters · filed 2026-04-28 | $4.64M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $2.30M derived: sum of 2 quarters · filed 2026-02-10 | $3.45M derived: sum of 3 quarters · filed 2026-02-10 | $4.54M 10-K · filed 2026-02-10 |
| 2025-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.30M derived: sum of 2 quarters · filed 2025-10-28 | $3.39M 10-Q · filed 2025-10-28 | $4.42M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $2.25M 10-Q · filed 2025-07-29 | $3.28M derived: sum of 3 quarters · filed 2026-04-28 | $4.26M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $1.09M 10-Q · filed 2026-04-28 | $2.13M derived: sum of 2 quarters · filed 2026-04-28 | $3.11M derived: sum of 3 quarters · filed 2026-04-28 | $4.02M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $2.02M derived: sum of 2 quarters · filed 2026-02-10 | $2.93M derived: sum of 3 quarters · filed 2026-02-10 | $3.80M 10-K · filed 2026-02-10 |
| 2024-09-30 | $979.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.89M derived: sum of 2 quarters · filed 2025-10-28 | $2.76M 10-Q · filed 2025-10-28 | $3.60M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $911.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $1.78M 10-Q · filed 2025-07-29 | $2.62M derived: sum of 3 quarters · filed 2026-02-10 | $3.50M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $871.00K 10-Q · filed 2025-04-29 | $1.71M derived: sum of 2 quarters · filed 2026-02-10 | $2.59M derived: sum of 3 quarters · filed 2026-02-10 | $3.43M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $837.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.72M derived: sum of 2 quarters · filed 2026-02-10 | $2.56M derived: sum of 3 quarters · filed 2026-02-10 | $3.36M 10-K · filed 2026-02-10 |
| 2023-09-30 | $885.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $1.72M derived: sum of 2 quarters · filed 2024-10-29 | $2.52M 10-Q · filed 2024-10-29 | $3.28M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $836.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $1.64M 10-Q · filed 2024-07-30 | $2.39M derived: sum of 3 quarters · filed 2025-02-10 | $3.13M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $802.00K 10-Q · filed 2024-04-30 | $1.56M derived: sum of 2 quarters · filed 2025-02-10 | $2.30M derived: sum of 3 quarters · filed 2025-02-10 | $3.00M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $1.49M derived: sum of 2 quarters · filed 2025-02-10 | $2.19M derived: sum of 3 quarters · filed 2025-02-10 | $2.86M 10-K · filed 2025-02-10 |
| 2022-09-30 | $738.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $1.44M derived: sum of 2 quarters · filed 2023-10-31 | $2.11M 10-Q · filed 2023-10-31 | $2.73M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $1.37M 10-Q · filed 2023-08-01 | $2.00M derived: sum of 3 quarters · filed 2024-02-13 | $2.61M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $668.00K 10-Q · filed 2023-05-02 | $1.30M derived: sum of 2 quarters · filed 2024-02-13 | $1.91M derived: sum of 3 quarters · filed 2024-02-13 | $2.51M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $629.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $1.24M derived: sum of 2 quarters · filed 2024-02-13 | $1.84M derived: sum of 3 quarters · filed 2024-02-13 | $2.42M 10-K · filed 2024-02-13 |
| 2021-09-30 | $615.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $1.22M derived: sum of 2 quarters · filed 2022-11-01 | $1.79M 10-Q · filed 2022-11-01 | $2.00M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $1.17M 10-Q · filed 2022-08-02 | $1.39M derived: sum of 3 quarters · filed 2023-02-07 | $1.62M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $573.00K 10-Q · filed 2022-05-03 | $790.00K derived: sum of 2 quarters · filed 2023-02-07 | $1.02M derived: sum of 3 quarters · filed 2023-02-07 | $1.22M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $449.00K derived: sum of 2 quarters · filed 2023-02-07 | $649.00K derived: sum of 3 quarters · filed 2023-02-07 | $836.00K 10-K · filed 2023-02-07 |
| 2020-09-30 | $232.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $432.00K derived: sum of 2 quarters · filed 2021-11-02 | $619.00K 10-Q · filed 2021-11-02 | $815.00K derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $387.00K 10-Q · filed 2021-08-03 | $583.00K derived: sum of 3 quarters · filed 2022-02-08 | $800.00K derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $187.00K 10-Q · filed 2021-05-04 | $383.00K derived: sum of 2 quarters · filed 2022-02-08 | $600.00K derived: sum of 3 quarters · filed 2022-02-08 | $814.00K derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $413.00K derived: sum of 2 quarters · filed 2022-02-08 | $627.00K derived: sum of 3 quarters · filed 2022-02-08 | $822.00K 10-K · filed 2022-02-08 |
| 2019-09-30 | $217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $431.00K derived: sum of 2 quarters · filed 2020-11-05 | $626.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $409.00K 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $195.00K 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |